Published on 2 Mar 2024 on Simply Wall St. via Yahoo Finance
A week ago, Silk Road Medical, Inc (NASDAQ:SILK) came out with a strong set of full-year numbers that could potentially lead to a re-rate of the stock. Silk Road Medical beat expectations with revenues of US$177m arriving 3.1% ahead of forecasts. The company also reported a statutory loss of US$1.44, 3.7% smaller than was expected. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.
Check out our latest analysis for Silk Road Medical
earnings-and-revenue-growth